Regarding the cause of the poor prognosis in high DSS1-expressing breast cancers, an intriguing observation is the marked enhancement of drug sensitivity in highly drug-resistant MDA-MB-231 breast cancer cells by DSS1 knockdown (Figure 4). This evidence concerns the gene SEM1 and breast cancer.